 |
| Site navigation |
|
|
|
| Conferences, Seminars and Workshops |
IACMAC activity plan (2020)
- V Central Russian Conference on Antimicrobial Therapy and Clinical Microbiology (October 15-16, online)
- Certification workshop of professional education on specialty “Bacteriology” (October 26 – November 26, Smolensk)
- XXII International Congress on Antimicrobial Chemotherapy and Clinical Microbiology (November 24–26, online)
|
|
| Studies |
Dear colleagues! We encourage to take part in multicenter prospective microbiological study of the antimicrobial resistance of community-acquired pathogens: S. pneumoniae, H. influenzae and S. pyogenes (PeGAS study). |
Since 2015 IAC and IACMAC have conducted multicenter study aimed to evaluate the prevalence of mutation resistance to macrolide antibiotic in Mycoplasma pneumonia and Mycoplasma genitalium. |
|
| Website News |
European Committee on Antimicrobial Susceptibility Testing (EUCAST) has amended the clinical classification of susceptibility (categories S,I and R): currently the clinical evaluation of susceptibility is connected with drug exposure in the nidus of infection. |
The occupational standard on specialty "Medical microbiology" from the Ministry of Healthcare of the Russian Federation is posted on IACMAC website. |
Clinical guidelines on diagnostics and treatment of community-acquired pneumonia in adults.
The Russian Respiratory Society (RRC) and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) have published for discussion the clinical guidelines on diagnostics and treatment of community-acquired pneumonia in adults. |
Clinical guidelines “Mucoviscidosis: microbiological diagnostics of chronic respiratory infection” |
Clinical guidelines on antimicrobial susceptibility testing, approved at the IACMAC extended session in Moscow are posted on the website.
Clinical guidelines on isolation, identification and antimicrobial susceptibility of Helicobacter pylori are added. |
|
| New Articles |
|
|
|
| Merck announced that its investigational 15-valent pneumococcal conjugate vaccine, or V114, was noninferior in protecting against the serotypes included in Pfizer’s 13-valent vaccine in children aged 6 to 12 weeks. V114 also produced an immune response in infants for two additional serotypes that cause disease — 22F and 33F. |
Jul 24, 2019 - 10:20 |
|
|
|
| As ocean temperatures increase, serious Vibrio vulnificus infections are on the rise in previously nonendemic areas, according to a case series published online in Annals of Internal Medicine. |
Jul 23, 2019 - 09:40 |
|
|
|
| Staphylococcus aureus was present on 40% of sampled cell phones of university students, mostly belonging to nursing students, according to findings presented at ASM Microbe. |
Jul 22, 2019 - 10:15 |
|
|
|
| The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients 18 years and older. The FDA initially approved Zerbaxa in 2014 to treat complicated intra-abdominal infections and for complicated urinary tract infections. |
Jun 13, 2019 - 11:20 |
|
|
|
| To compare the risk of serious infection associated with biologic and nonbiologic systemic medications in patients with psoriasis. |
Jun 03, 2019 - 10:05 |
|
|
|
| This study uses in vitro assays and a mouse model to investigate antibacterial properties of ticagrelor to follow up findings from 2 clinical trials that showed patients taking ticagrelor for cardiovascular disease had a lower risk of infection-related death and improved lung function compared with patients treated with clopidogrel. |
Jun 01, 2019 - 10:10 |
|
|
|
| Risk factors for maternal infection are clearly recognised, including caesarean section and operative vaginal birth. Antibiotic prophylaxis at caesarean section is widely recommended because there is clear systematic review evidence that it reduces incidence of maternal infection. Current WHO guidelines do not recommend routine antibiotic prophylaxis for women undergoing operative vaginal birth because of insufficient evidence of effectiveness. We aimed to investigate whether antibiotic prophylaxis prevented maternal infection after operative vaginal birth. |
May 31, 2019 - 11:05 |
|
|
|
| The increasing multidrug resistance among gram-negative uropathogens necessitates new treatments for serious infections. Plazomicin is an aminoglycoside with bactericidal activity against multidrug-resistant (including carbapenem-resistant) Enterobacteriaceae. |
May 30, 2019 - 10:15 |
|
|
|
| Brucellosis is a common global zoonotic disease, which is responsible for a range of clinical manifestations. Fever, sweating and musculoskeletal pains are observed in most patients. The most frequent complication of brucellosis is osteoarticular involvement, with 10% to 85% of patients affected. |
May 29, 2019 - 12:15 |
|
|
|
| Honey dressing has been applied in the treatment of diabetic foot ulcers (DFUs). However, there is a lack of research showing ample evidence that honey dressing is more effective in the treatment of DFUs than other dressings. This study aimed to examine the effects of honey dressing on wound-healing process for DFUs. |
Mar 20, 2019 - 10:15 |
|
|
